Dutasteride

Dutasteride (trademark name Avodart, manufactured by GlaxoSmithKline) is a dual 5-a reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT).

Dutasteride is approved by the Food and Drug Administration (FDA) for treatment of benign prostatic hyperplasia (BPH) and prescribed off-label for treatment of male pattern baldness (MPB).

Read more about DutasterideContraindications, Mechanism of Action, Chemical Synthesis

Other articles related to "dutasteride":

Management Of Baldness - Medications - Dutasteride
... Dutasteride is a dual 5-a reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT) ... Dutasteride inhibits both isoforms of 5-alpha reductase, type I and type II, whereas finasteride only inhibits type II ... Dutasteride (trademark name Avodart, manufactured by GlaxoSmithKline) is approved for the treatment of benign prostatic hyperplasia (BPH) ...